Literature DB >> 25115554

Long-Term Follow-Up of Patients at High Risk for Nephropathy After Contrast Exposure.

Okay Abaci1, Ozlem Harmankaya2, Betul Kocas3, Cuneyt Kocas3, Cem Bostan3, Ugur Coskun3, Ahmet Yildiz3, Murat Ersanli3.   

Abstract

Contrast medium-induced acute kidney injury (CI-AKI) is associated with morbidity and mortality, but the long-term outcomes of patients who do not develop CI-AKI remain unknown. We assessed clinical end points during long-term follow-up in patients at high risk for nephropathy who did not develop CI-AKI. Patients (n = 135) with impaired renal function (estimated glomerular filtration rate: 30-60 mL/min/1.73 m(2)) were divided into 2 groups according to contrast media (CM) exposure. The primary end point of this study was a composite outcome measure of death or renal failure requiring dialysis. Multivariate analyses identified CM exposure to be independently associated with major adverse long-term outcomes (hazard ratio: 2.3; 95% confidence interval, 1.34-6.52; P = .018). Even when CM exposure does not cause CI-AKI in patients with impaired renal function, in the long term, primary end points occur more frequently in patients exposed to CM than in those with no CM exposure.
© The Author(s) 2014.

Entities:  

Keywords:  contrast media exposure; impaired renal function; long-term follow-up

Mesh:

Substances:

Year:  2014        PMID: 25115554     DOI: 10.1177/0003319714546527

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  5 in total

1.  The impact of percutaneous coronary intervention using the novel dynamic coronary roadmap system.

Authors:  Takayuki Yabe; Toshiya Muramatsu; Reiko Tsukahara; Masatsugu Nakano; Hideyuki Takimura; Mami Kawano; Tasuku Hada; Takanori Ikeda
Journal:  Heart Vessels       Date:  2019-09-14       Impact factor: 2.037

2.  Acute kidney injury following endovascular intervention for peripheral artery disease.

Authors:  E Katsogridakis; T Lea; T Yap; A Batchelder; P Saha; A Diamantopoulos; N Saratzis; R Davies; H Zayed; M J Bown; A Saratzis
Journal:  Br J Surg       Date:  2021-03-12       Impact factor: 6.939

Review 3.  Contrast-Induced Nephropathy: A Review of Mechanisms and Risks.

Authors:  Elham Shams; Harvey N Mayrovitz
Journal:  Cureus       Date:  2021-05-04

4.  Relaxin Attenuates Contrast-Induced Human Proximal Tubular Epithelial Cell Apoptosis by Activation of the PI3K/Akt Signaling Pathway In Vitro.

Authors:  Xiang-Cheng Xie; Yizhi Cao; Xiu Yang; Qun-Hong Xu; Wei Wei; Ming Wang
Journal:  Biomed Res Int       Date:  2017-04-30       Impact factor: 3.411

5.  Intravenous N-acetylcysteine for the PRevention Of Contrast-induced nephropathy - a prospective, single-center, randomized, placebo-controlled trial. The INPROC trial.

Authors:  Barbara Biernacka-Fiałkowska; Marta Szuksztul; Wojciech Suślik; Karolina Dzierwa; Łukasz Tekieli; Magdalena Kostkiewicz; Piotr Podolec; Piotr Pieniążek
Journal:  Postepy Kardiol Interwencyjnej       Date:  2018-03-22       Impact factor: 1.426

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.